Let's spread the word about Immunotherapy! Click to share this page with your community.

Cancer Immunotherapy: 2020 Research Update and a Look Ahead

Each year, advances in immunotherapy bring its lifesaving benefits to bear against more and more types of cancers. In addition to novel treatment strategies, a better understanding of immunotherapy’s mechanisms is allowing doctors to tailor their approaches to fit individual patients.

In this webinar for patients and caregivers, Padmanee Sharma, M.D., Ph.D., of the University of Texas MD Anderson Cancer Center, discusses what breakthroughs and advances might lie ahead for the field of cancer immunotherapy in 2020 by highlighting the challenges and opportunities at the cutting-edge of immuno-oncology.

Dr. Padmanee Sharma, MD Anderson Cancer CenterDr. Padmanee Sharma is a Professor in the departments of Genitourinary Medical Oncology and Immunology, and the Scientific Director for the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center. She is also the Co-Director of Parker Institute for Cancer Immunotherapy at MD Anderson Cancer Center. She is a trained medical oncologist and immunologist whose research work is focused on investigating mechanisms and pathways within the immune system that are responsible for tumor rejection and clinical benefit. She is the Principal Investigator of multiple immunotherapy clinical trials and conducts translational laboratory studies related to these trials. Her studies enable development of novel immunotherapy strategies for the treatment of cancer patients.

Dr. Sharma received the Emil Frei III Award for Excellence in Translational Research in 2016 and was inducted into the American Society for Clinical Investigation (ASCI) in 2018. She is the recipient of the 2018 William B. Coley Award for Distinguished Research in Tumor Immunology. In addition to the CRI Scientific Advisory Council, she is a member of the CRI Clinical Accelerator Clinical and Scientific Advisory Committee.

The "Cancer Immunotherapy and You" webinar series is produced by the Cancer Research Institute and is hosted by our science writer, Arthur Brodsky, Ph.D. The 2020 series is made possible with generous support from Bristol-Myers Squibb and Foundation Medicine.
 
Browse our Cancer Immunotherapy and You Webinar Series playlist on YouTube or visit the Webinars page on our website to see other webinars in this series.

Bristol-Myers Squibb and Foundation Medicine

 

*Immunotherapy results may vary from patient to patient.

Top